The U.S. Congress approved last month, increasing 2003 budgets of both the National Institutes of Health and National Science Foundation. America is not alone in - vainly - trying to compensate for imploding capital markets and financial risk aversion.
In 1999, Gordon Brown has begun a program of 1.6 billion U.S. dollars' Restructuring British science and market its products. This site $ 1000000000 invested between 1998-2002. Budgets Medical Research Council and Biotechnology and Biological Sciences Research Council were quadrupled overnight.
University Challenge Fund was established to provide 100 million dollars in seed money to cover the cost of hiring management skills, securing intellectual property, build a prototype or preparation of a business plan. Another 30 million dollars of U.S. funding startup high-tech venture businesses in the United Kingdom.
The United Nations Development Program (UNDP), investing in top 29 industrialized countries in R & D more than $ 600 billion per year. Most of these funds provided by the private sector. In the United Kingdom, for example, state funds dwarfed by private financing, according to the British Venture Capital Association. More than 80 billion dollars have been plowed into 23,000 companies since 1983, about half of them in the hi-tech sector. Three million people are employed in these enterprises. Investments grew by 36 per cent in 2001 to 18 bn.
But this British exuberance is a global exception.
Even the - white-hot life - sciences has declined about 11 percent of venture capital investments in the past year, reports the Money-tree Survey. According to Ernst & Young 2002 Alberta Technology Information published on Wednesday, the Canadian high technology languishes below $ 3 billion invested in 2002 in seed capital - this despite generous matching funds and tax credits offered by most of the provinces and the federal government.
Israel, venture capital fell to 600 million U.S. dollars last year - the fifth in 2000. Aware of this revolutionary reversal in investor sentiment, the Israeli government set up 24 hi-tech business incubators. But they can only partly pecuniary food needs of 20 per cent of the projects.
While governments take over monumental created by the withdrawal of private funds, they attempt to streamline and save.
New Jersey Commission of Health Science Education and Training recently proposed to combine the status of the three public research universities. The surge of federal and state budget deficit is likely to be subject to greater pressure on already strained relations between universities and the state - particularly with regard to research priorities and the sharing of scarce resources.
This friction is inevitable because the interaction between technology and science is complex and poorly understood. Some technological developments spawn new scientific fields - the steel industry gave birth to metallurgy, computers, information technology and transistor is a solid-state physics. Discoveries in science, however, usually leads to deviations, technological innovations - in the examples of semiconductors and biotechnology.
Therefore, it is safe to generalize and say that the technology sector is only visible and attractive to the tip of the iceberg drabber research and development. Military, universities, research institutes and industry all over the world hundreds of billions annually aura of both basic and applied studies. But governments are the primary sponsors pure scientific pursuits, almost everything.
Science is broadly perceived as a public good - the benefits are shared. Rational individuals would do well to take a step back and copy the results of the investigation - rather than producing them widely replicated discoveries themselves. The government should intervene to provide incentives for innovation.
So that most laymen and many economists, science refers only to public funding of universities and the military government. Inventions such as jet and the Internet are often touted as examples of benefits from research financed by public funds civil military. Pharmaceutical, biomedical, information technology and aerospace, for instance - though largely private - rely heavily on fruits uncompetitive (ie public) science sponsored by the State.
Most 501 businesses surveyed by the Ministry of Finance and Revenue Canada in 1995-6 reported that public funding improved cash flow - an important consideration in the decision to undertake the investigation and development. Most of the beneficiaries of tax incentives claimed by seven years and employment growth.
Due to capital markets, and some venture capitalists, some developing countries have taken this trend to extremes. The Philippines, nearly 100 percent of R & D is funded by the government. Melt and flows of foreign direct investment - fell by nearly three fifths since 2000 - only the intervention of the state in most need.
But this is not a universal trend. South Korea, for example, made a successful transition to private venture capital which now - even after the 1997 Asian crisis and global recession of 2001 - amounts to four fifths of all R & D.
It is supported through a public cling science is exaggerating. Most applied R & D continues to play a clothing privately owned industry. Even science 'pure - real greed and commerce - is sometimes financed by private donations and foundations.
In addition, the channels of government involvement in research, universities are only weakly correlated with growing prosperity. As Alison Wolf, professor of education at the University of London highlights in his seminal work "Does Education Matter? Myths about Education and Economic Growth" was published last year, years additional education and wider access to university does not necessarily lead to growth has increased (though technological innovation clearly does).
Terence Kealey, a clinical biochemist, vice-chancellor of the University of Buckingham in England and author of The Economic Laws of Scientific Research, is part of a growing group of researchers who deny intuitive connection between science through state and economic progress. In an interview published last week by the journal Scientific American, he recounted how he discovered that:
"All the major industrial countries, Japan - a country investing least in science - grew the fastest. Japanese science grew spectacularly under laissez-faire. Science is actually cleaner than the UK or the U.S. with countries in the first of at least investment were France and Germany, and growing next fastest. And the greatest investment were the United States, Canada and the United Kingdom, which are doing very badly about."
Economist same thing: It's difficult to choose the winners in government technology. Innovations in science and sprout in - or migrate - the place where the harsh laws of intellectual property rights, a functioning financial system, culture "think outside the box" and the tradition of excellence.
Government can only remove obstacles - especially red tape and trade tariffs - problems and move in the right direction by investing in infrastructure and institutions. Tax incentives are essential to begin with. But if the authorities intervene, they are safe to destroy science and be Rued researchers.
Still, all forms of science funding - both public and private - are lacking.
generosity of the state is ideologically narrow, long-suffering miss-allocated, inefficient and erratic. U.S. mega-projects like the Superconducting Super Collide, with billions already sunk in, is suddenly killed were several other defense systems. Additionally, some information suggests the research funded by the government was locked in public.
But industrial money can be worse. It is unconditional. Negative results of drug studies have been suppressed by corporate donors more than once, for example. Commercial entities are unlikely to support basic research and publicly available, eventually returned to its competitors as a benefit of overflow. This understandable reluctance stifles innovation.
There is no lack of suggestions on how to square this circle.
Quoted in Philadelphia Business Journal, Donald Drakeman CEO of the Princeton biotech company Medarex proposed last month to encourage drug companies to overcome the technology they have chosen to defer: As you can see small business comes from research conducted at Harvard and MIT in Massachusetts and Stanford and Berkley in California, could be done by Johnson & Johnson and Merck.
This is the company responsible Bayh-Dole Act in 1980. The basic rule is made as well as universities and researchers the owners of inventions or discoveries financed by government agencies. This triggered an unprecedented wave of self-financing companies.
In the two decades that followed, the number of patents to universities increased tenfold, and spread over 2,200 companies in marketing research. In the process, which generated 40 billion U.S. dollars of gross national product and created 260 000 jobs.
None of this was funded by the government - even if, according to The Economist Technology Quarterly, $ 1 in research usually requires up to $ 10,000 in capital coming into the market. This suggests a clear and mutually beneficial labor - governments should picks up the tab for basic research, private capital should do the rest, stimulated by the transfer of intellectual property of the state for entrepreneurs.
But this raises a host of contentious issues.
Such a system may affect the industry depends on the advancement of pure science, as a kind of hidden. The research priorities are inevitably politicized and lead to a massive allocation of scarce economic resources through pork barrel politics and the use of national goals. NASA and its Let Man on the Moon (before the Soviet Union do) stupid and International Space Station is an unhappy sign of such risks.
Science is only the public interest, which is produced by individuals rather than collective. This inner conflict is difficult to solve. On the other hand, because public money to enrich entrepreneurs? On the other hand, profit-driven investors seek temporary monopolies in the form of intellectual property rights. Because they share this cornucopia with others, as pure scientists forced to do?
Partnership in basic and applied science has always been a troubled one. Has grown so returns the money to scientific knowledge has increased and the capital available for commercialization multiplied. The future of science is at stake.
Governments were to leave the area, probably collapse of basic research. Were they to micromanage - applied science and entrepreneurship would suffer. It's a delicate balance, and judging by the current to both universities and startups, a precarious way.
No comments:
Post a Comment